Google
Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Hydroxyurea Treatment for Sickle Cell Disease – Children’s National Health System
source: Children's National Health System
year: N/A
summary/abstract:At Children’s National, we understand that families affected by sickle cell disease have many questions about their child’s treatment. We are dedicated to connecting you with information to help you understand how hydroxyurea can help children manage sickle cell disease.
What is hydroxyurea?
Hydroxyurea is a medicine that prevents pain that occurs from sickle cell disease. It comes in pill and liquid forms.
What are its benefits?
It helps reduce:
-Pain crisis
-Acute chest syndrome (pneumonia that occurs in sickle cell disease)
-Strokes
-The need for blood transfusions
-Hospitalizations
read more
+myBinderRelated Content
-
How we treat delayed haemolytic transfusion reactions in patients with sickle cell diseaseTransfusion therapy is effective in the ...
-
Transfusion-Induced iron overloadThe human body has no active mechanism f...
-
Imara Reports Favorable Preclinical and Phase 1 Data on IMR-687 in Sickle Cell DiseaseImara Inc. today announced it will repor...
-
Bioverativ and Sangamo announce FDA acceptance of IND application for gene-edited cell therapy BIVV003 to treat sick...Bioverativ Inc., a Sanofi company dedi...
-
Progress in pursuit of sickle cell cureBao, in collaboration with Baylor Colleg...
-
Gene therapies could transform the treatment of sickle cell diseaseManny Johnson keeps catching h...
-
Yoga for Chronic Pain – US Pain FoundationDuring this interactive live webinar, in...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.